title: Thrombocytosis, neutrophilia and anemia during interleukin-2 therapy.
authors.forename: F
authors.initials: F
authors.lastname: Rossini
authors.forename: F
authors.initials: F
authors.lastname: Brivio
authors.forename: S
authors.initials: S
authors.lastname: Mingozzi
authors.forename: P
authors.initials: P
authors.lastname: Lissoni
authors.forename: P
authors.initials: P
authors.lastname: Pioltelli
mesh_terms: D002292:Carcinoma, Renal Cell / Q000628:therapy; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy; D007964:Leukocytosis / Q000139:chemically induced*; D008875:Middle Aged; D009504:Neutrophils; D013922:Thrombocytosis / Q000139:chemically induced*
chemical_list: D007155:Immunologic Factors; D007376:Interleukin-2